Draft Medical Policies

To ensure that the development of medical policies occurs through an open, collaborative process, we welcome comments about medical policies that are in the draft stage. Our current draft policies are listed below.

Participating providers are invited to submit scientific, evidence-based information, professional consensus opinions and other information supported by medical literature relevant to these draft policies for consideration. We accept comments for 45 days from the posting date listed on the draft policy document.

Note: Coverage is subject to member's specific benefits. Group-specific policies will supersede these policies when applicable. Please refer to member's benefit plan.

How to Submit Comments on Draft Medical Policies

Complete our medical policy feedback form

Or send comments by mail or fax to:

Blue Cross and Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001

Fax: 205-220-0878

 

Policy # Policy Title Print View
MP-168 Cardioverter Defibrillator: Implantable
MP-341 Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease
MP-405 JAK2, MPL, and CALR Testing for Myeloproliferative Neoplasms
MP-485 Hematopoietic Cell Transplantation for Autoimmune Diseases
MP-557 Cardioverter Defibrillators: Wearable or External
MP-621 Surgical Treatment of Snoring and Obstructive Sleep Apnea
MP-724 Hydrogel Spacer use During Radiotherapy for Prostate Cancer